Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy

被引：0

作者：

Francesca Rapino

Sylvain Delaunay

Florian Rambow

Zhaoli Zhou

Lars Tharun

Pascal De Tullio

Olga Sin

Kateryna Shostak

Sebastian Schmitz

Jolanda Piepers

Bart Ghesquière

Latifa Karim

Benoit Charloteaux

Diane Jamart

Alexandra Florin

Charles Lambert

Andrée Rorive

Guy Jerusalem

Eleonora Leucci

Michael Dewaele

Marc Vooijs

Sebastian A. Leidel

Michel Georges

Marianne Voz

Bernard Peers

Reinhard Büttner

Jean-Christophe Marine

Alain Chariot

Pierre Close

机构：

[1] University of Liège,Laboratory of Cancer Signaling

[2] University of Liège,GIGA

[3] KU Leuven,institute

[4] Center for Cancer Biology,Laboratory for Molecular Cancer Biology, Department of Oncology

[5] VIB,Institute for Pathology

[6] University Hospital Cologne,Centre for Interdisciplinary Research on Medicines (CIRM)

[7] University of Liège,Faculty of Medicine

[8] Max Planck Research Group for RNA Biology,Cells

[9] Max Planck Institute for Molecular Biomedicine,in

[10] University of Münster,Motion Cluster of Excellence

[11] University of Münster,Laboratory of Medical Chemistry

[12] University of Liège,Department of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology

[13] Maastricht University,Metabolomics Core Facility

[14] Center for Cancer Biology,Unit of Animal Genomics

[15] VIB,Medical Oncology, CHU Sart Tilman Liège

[16] University of Liège,undefined

[17] University of Liège,undefined

[18] WELBIO,undefined

[19] University of Liège,undefined

来源：

Nature | 2021年 / 599卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：E14 / E14

共 50 条

[31] Author Correction: Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors
Jie Zhu
Chang Ming
Xin Fu
Yaou Duan
Duc Anh Hoang
Jeffrey Rutgard
Runze Zhang
Wenqiu Wang
Rui Hou
Daniel Zhang
Edward Zhang
Charlotte Zhang
Xiaoke Hao
Wenjun Xiong
Kang Zhang
Cell Research, 2019, 29 : 337 - 337
[32] Author Correction: Selection of a subspecies-specific diterpene gene cluster implicated in rice disease resistance
Chuansong Zhan
Long Lei
Zixin Liu
Shen Zhou
Chenkun Yang
Xitong Zhu
Hao Guo
Feng Zhang
Meng Peng
Meng Zhang
Yufei Li
Zixin Yang
Yangyang Sun
Yuheng Shi
Kang Li
Ling Liu
Shuangqian Shen
Xuyang Wang
Jiawen Shao
Xinyu Jing
Zixuan Wang
Yi Li
Tomasz Czechowski
Morifumi Hasegawa
Ian Graham
Takayuki Tohge
Lianghuan Qu
Xianqing Liu
Alisdair R. Fernie
Ling-Ling Chen
Meng Yuan
Jie Luo
Nature Plants, 2021, 7 : 100 - 100
[33] Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies
Yan Li
Chen Xu
Bing Wang
Fujiang Xu
Fahan Ma
Yuanyuan Qu
Dongxian Jiang
Kai Li
Jinwen Feng
Sha Tian
Xiaohui Wu
Yunzhi Wang
Yang Liu
Zhaoyu Qin
Yalan Liu
Jing Qin
Qi Song
Xiaolei Zhang
Akesu Sujie
Jie Huang
Tianshu Liu
Kuntang Shen
Jian-Yuan Zhao
Yingyong Hou
Chen Ding
Nature Communications, 13
[34] Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy
Zhou, Qin
Tu, Xinyi
Hou, Xiaonan
Yu, Jia
Zhao, Fei
Huang, Jinzhou
Kloeber, Jake
Olson, Anna
Gao, Ming
Luo, Kuntian
Zhu, Shouhai
Wu, Zheming
Zhang, Yong
Sun, Chenyu
Zeng, Xiangyu
Schoolmeester, Kenneth J.
Weroha, John S.
Hu, Xiwen
Jiang, Yanxia
Wang, Liewei
Mutter, Robert W.
Lou, Zhenkun
DRUG RESISTANCE UPDATES, 2024, 74
[35] Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
Julia Boshuizen
David W. Vredevoogd
Oscar Krijgsman
Maarten A. Ligtenberg
Stephanie Blankenstein
Beaunelle de Bruijn
Dennie T. Frederick
Juliana C. N. Kenski
Mara Parren
Marieke Brüggemann
Max F. Madu
Elisa A. Rozeman
Ji-Ying Song
Hugo M. Horlings
Christian U. Blank
Alexander C. J. van Akkooi
Keith T. Flaherty
Genevieve M. Boland
Daniel S. Peeper
Nature Communications, 14
[36] Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy
Katopodi, Theodora
Petanidis, Savvas
Grigoriadou, Eirini
Anestakis, Doxakis
Charalampidis, Charalampos
Chatziprodromidou, Ioanna
Floros, George
Eskitzis, Panagiotis
Zarogoulidis, Paul
Koulouris, Charilaos
Sevva, Christina
Papadopoulos, Konstantinos
Roulia, Panagiota
Mantalovas, Stylianos
Dagher, Marios
Karakousis, Alexandros Vasileios
Varsamis, Nikolaos
Vlassopoulos, Konstantinos
Theodorou, Vasiliki
Mystakidou, Chrysi Maria
Katsios, Nikolaos Iason
Farmakis, Konstantinos
Kosmidis, Christoforos
PHARMACEUTICS, 2024, 16 (04)
[37] Overcoming drug resistance with specific nano scales to targeted therapy: Focused on metastatic cancers
Kadhum, Wesam R.
Majeed, Ali A.
Saleh, Raed Obaid
Ali, Eyhab
Alhajlah, Sharif
Alwaily, Enas R.
Mustafa, Yasser Fakri
Ghildiyal, Pallavi
Alawadi, Ahmed
Alsalamy, Ali
PATHOLOGY RESEARCH AND PRACTICE, 2024, 255
[38] P-Rex1 Promotes Resistance to VEGF/VEGFR-Targeted Therapy in Prostate Cancer
Goel, Hira Lal
Pursell, Bryan
Shultz, Leonard D.
Greiner, Dale L.
Brekken, Rolf A.
Vander Kooi, Craig W.
Mercurio, Arthur M.
CELL REPORTS, 2016, 14 (09): : 2193 - 2208
[39] Macroautophagy/autophagy promotes resistance to KRASG12D-targeted therapy through glutathione synthesis
Han, Leng
Meng, Lingjun
Liu, Jiao
Xie, Yangchun
Kang, Rui
Klionsky, Daniel J.
Tang, Daolin
Jia, Yuanyuan
Dai, Enyong
CANCER LETTERS, 2024, 604
[40] Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Martina S. J. McDermott
Brigid C. Browne
Neil T. Conlon
Neil A. O’Brien
Dennis J. Slamon
Michael Henry
Paula Meleady
Martin Clynes
Paul Dowling
John Crown
Norma O’Donovan
Molecular Cancer, 22

← 1 2 3 4 5 →